Fresenius Invests in BioIntellisense AI Platform
“We made this strategic investment in BioIntelliSense to enable our medical staff to more efficiently and effectively continuously monitor patients, facilitating precise and timely interventions and reducing cost to the system,” explains FMCNA CEO, Bill Valle.
Read the full article » | Posted 09-12-2019
Related Articles
- ISPD’s Spotlight Webinar Series 2026 Posted 03-12-2026
- Dr. Brigitte Schiller Shares Thoughts on Prescribing Nocturnal Home HD Posted 03-12-2026
- Dr. Chris Chan and Dr. Klement Yeung: Treat Home HD as an Established Modality Posted 03-12-2026
- How to Get Started: Your Path to Home Dialysis – New AKF Webinar Posted 03-12-2026